Prescription Drug Ads Could Be Changing. These Stocks Could Get Hurt the Most.

Core Viewpoint - The article discusses the regulatory stance on advertisements, indicating that while there will be restrictions, a complete ban on certain ads is not being implemented [1] Group 1 - The ads in question will face limitations but will not be banned outright, suggesting a more moderate regulatory approach [1]